GHAZWAN ACASH

Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease BURLINGTON, MA NPI 1710187331

General Payments — all program years on this page

$2,583.39

  • Category: General Payments
  • Program years: PY2020–2024
  • Record count: 55
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,090.71 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $825.001
Food and Beverage $230.7312
Education $34.981

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Gyrus ACMI, Inc. $825.001
Acerta Pharma LLC $181.099
GENZYME CORPORATION $24.391
Mylan Specialty L.P. $21.671
JAZZ PHARMACEUTICALS INC. $21.491
GlaxoSmithKline, LLC. $17.071

By program year

Program yearAmountRecords
2020 $712.634
2021 $44.883
2022 $175.098
2023 $560.0826
2024 $1,090.7114

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1099612837 Gyrus ACMI, Inc. $825.00 03/11/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1104266779 AstraZeneca Pharmaceuticals LP $15.16 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104376773 AstraZeneca Pharmaceuticals LP $7.44 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104391295 AstraZeneca Pharmaceuticals LP $29.85 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104410893 AstraZeneca Pharmaceuticals LP $17.68 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104684393 AstraZeneca Pharmaceuticals LP $20.28 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104747097 AstraZeneca Pharmaceuticals LP $16.49 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105610461 AstraZeneca Pharmaceuticals LP $19.82 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105788684 AstraZeneca Pharmaceuticals LP $34.98 11/06/2024 Education Undisputed 01/23/2026 View at CMS
1105853930 AstraZeneca Pharmaceuticals LP $19.39 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116180234 GlaxoSmithKline, LLC. $17.07 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139971413 GENZYME CORPORATION $24.39 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147363495 Mylan Specialty L.P. $21.67 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150228693 JAZZ PHARMACEUTICALS INC. $21.49 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.